Blood Glucose
"Blood Glucose" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glucose in blood.
Descriptor ID |
D001786
|
MeSH Number(s) |
D09.947.875.359.448.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Blood Glucose".
Below are MeSH descriptors whose meaning is more specific than "Blood Glucose".
This graph shows the total number of publications written about "Blood Glucose" by people in this website by year, and whether "Blood Glucose" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 2 | 4 | 6 | 1996 | 1 | 10 | 11 | 1997 | 1 | 5 | 6 | 1998 | 1 | 6 | 7 | 1999 | 1 | 12 | 13 | 2000 | 2 | 10 | 12 | 2001 | 1 | 6 | 7 | 2002 | 5 | 7 | 12 | 2003 | 5 | 16 | 21 | 2004 | 13 | 12 | 25 | 2005 | 3 | 19 | 22 | 2006 | 7 | 18 | 25 | 2007 | 13 | 18 | 31 | 2008 | 12 | 21 | 33 | 2009 | 9 | 47 | 56 | 2010 | 15 | 26 | 41 | 2011 | 13 | 23 | 36 | 2012 | 14 | 29 | 43 | 2013 | 17 | 30 | 47 | 2014 | 26 | 42 | 68 | 2015 | 20 | 35 | 55 | 2016 | 23 | 35 | 58 | 2017 | 21 | 43 | 64 | 2018 | 33 | 46 | 79 | 2019 | 49 | 39 | 88 | 2020 | 24 | 57 | 81 | 2021 | 11 | 64 | 75 | 2022 | 9 | 75 | 84 | 2023 | 12 | 51 | 63 | 2024 | 32 | 49 | 81 | 2025 | 8 | 22 | 30 |
To return to the timeline, click here.
Below are the most recent publications written about "Blood Glucose" by people in Profiles.
-
Mitro SD, Waetjen LE, Lee C, Wise LA, Zaritsky E, Harlow SD, El Khoudary SR, Santoro N, Solomon DH, Thurston RC, Hedderson MM. Diabetes and Uterine Fibroid Diagnosis in Midlife: Study of Women's Health Across the Nation (SWAN). J Clin Endocrinol Metab. 2025 May 19; 110(6):e1934-e1942.
-
van Baar MJB, Muskiet MHA, Scholtes RA, Touw DJ, Nieuwdorp M, Kramer MHH, Joles JA, Cherney DZI, Bjornstad P, Krebber MM, van Raalte DH. Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono- and combination therapy compared to gliclazide in overweight people with type 2 diabetes (RACELINES): A randomised, double-blind trial. Diabetes Obes Metab. 2025 Jul; 27(7):3943-3956.
-
Mann EA, Rompicherla S, Miyazaki B, Rioles N, Hardison H, Golden L, Sarhis J, Akturk HK, Lee J, DeSalvo DJ, Gomez P, Ebekozien O, Prahalad P. Early Continuous Glucose Monitor Use in Children and Adolescents With Type 1 Diabetes: Rates of Initiation and Impact on Glycemic Outcomes. Diabetes Care. 2025 May 01; 48(5):768-775.
-
Parmer HW, Miles MVP, Friedrich K, Mitchell L, Jones J, Day L, Wilson AW, Mejia VA. Stress Hyperglycemia Is Associated With Similar Mortality and Complication Rates Compared to Trauma Patients With Diabetes. J Surg Res. 2025 May; 309:124-129.
-
Berget C, Annan SF, Biester T, Choudhary P, Forlenza GP, Peters AL, Renard E, Deiss D. Practical considerations for using the Omnipod? 5 Automated Insulin Delivery System: Clinical experience from the United States and Europe. Diabetes Obes Metab. 2025 Jun; 27(6):2909-2919.
-
Hall TL, Dickinson LM, Warman MK, Oser TK, Oser SM. Continuous glucose monitoring among nurse practitioners in primary care: Characteristics associated with prescribing and resources needed to support use. J Am Assoc Nurse Pract. 2025 Apr 01; 37(4):207-216.
-
Utzschneider KM, Tripputi M, Butera NM, Mari A, Rosin SP, Banerji MA, Bergenstal RM, Brown N, Carlson AL, DeFronzo RA, Gramzinski MR, Harindhanavudhi T, Kozedub A, Sivitz WI, Steffes MW, Balasubramanyam A, Rasouli N. Differential Treatment Effects on ?-Cell Function Using Model-Based Parameters in Type 2 Diabetes: Results From the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care. 2025 Apr 01; 48(4):623-631.
-
Laubach ZM, Madden SA, Pardue A, Safran RJ. Does Parental Care Modify the Association of Early-Life Size and Growth with Physiology? Am Nat. 2025 May; 205(5):469-484.
-
Mason E, Karakus KE, Akturk HK. Barriers to glucagon use in patients with type 1 diabetes. Prim Care Diabetes. 2025 Jun; 19(3):341-343.
-
Garg SK, Bailey TS, Castorino K, Christiansen MP, Liljenquist DR, Salazar H, Akturk HK, Gao S, Johnson ML, Beck SE. Accuracy of the 15.5-Day G7 iCGM in Adults with Diabetes. Diabetes Technol Ther. 2025 Jun; 27(6):430-438.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|